Ono Pharmaceutical Co Ltd – Strategy, SWOT and Corporate Finance Report
- Pages: 53
- Published: July 2019
- Report Code: MLPH31988FSA
Ono Pharmaceutical Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzheimer’s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis among others. The company offers products in various formulations such as capsules, tablets, injections, patches, dry syrup and intravenous infusion. It offers its products in Americas, Europe and Asia. Ono Pharmaceutical is headquartered in Chuo-ku, Osaka, Japan.
Scope
Detailed information on Ono Pharmaceutical Co Ltd required for business and competitor intelligence needs
A study of the major internal and external factors affecting Ono Pharmaceutical Co Ltd in the form of a SWOT analysis
An in-depth view of the business model of Ono Pharmaceutical Co Ltd including a breakdown and examination of key business segments
News about Ono Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Ono Pharmaceutical Co Ltd and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Ono Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Ono Pharmaceutical Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Takeda Pharmaceutical Co Ltd
Sumitomo Dainippon Pharma Co Ltd
Kyowa Hakko Kirin Co Ltd
Fuji Pharma Co Ltd
Chugai Pharmaceutical Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.